GE HealthCare Technologies Stock Hits Key Support – Buying Opportunity?
GE HealthCare Technologies (GEHC) stock should be on your watchlist. Here is why – it is currently trading in the support zone ($71.01 – $78.49), levels from which it has bounced meaningfully before. In the last 10 years, GE HealthCare Technologies stock received buying interest at this level 4 times and subsequently went on to generate 24.0% in average peak returns.
| Peak Return | Days to Peak Return | |
|---|---|---|
| 1/23/2023 | 26.3% | 91 |
| 11/2/2023 | 12.8% | 54 |
| 1/24/2024 | 31.2% | 44 |
| 6/11/2024 | 25.6% | 111 |
Yet, a support zone alone isn’t enough; rebounds are more likely when fundamentals, sentiment, and market conditions line up. How does that look for GEHC?
Rebound likely; strategic growth outweighs near-term tariff/dilution.
GEHC’s Q3 2025 showcased robust organic revenue (3.5%) and orders (6%) growth, exceeding estimates, despite tariff-induced EPS pressure. The $2.3B Intelerad acquisition expands cloud-based imaging and SaaS offerings, aligning with MedTech’s AI and digital transformation tailwinds, potentially tripling cloud-enabled products by 2028. While short-term EPS dilution from financing is expected, strong backlog ($21.2B) and analyst “Buy” consensus with an average target over $86 indicate underlying strength and future upside.
How Do GEHC Financials Look Right Now?
- Revenue Growth: 3.5% LTM and 4.0% last 3-year average.
- Cash Generation: Nearly 6.9% free cash flow margin and 13.5% operating margin LTM.
- Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for GEHC was 0.0%.
- Valuation: GEHC stock trades at a PE multiple of 15.4
| GEHC | S&P Median | |
|---|---|---|
| Sector | Health Care | – |
| Industry | Health Care Equipment | – |
| PE Ratio | 15.4 | 22.6 |
|
|
||
| LTM* Revenue Growth | 3.5% | 6.1% |
| 3Y Average Annual Revenue Growth | 4.0% | 5.4% |
| Min Annual Revenue Growth Last 3Y | – | 0.2% |
|
|
||
| LTM* Operating Margin | 13.5% | 18.8% |
| 3Y Average Operating Margin | 13.1% | 18.2% |
| LTM* Free Cash Flow Margin | 6.9% | 13.5% |
*LTM: Last Twelve Months
And What If The Support Breaks?
GEHC isn’t immune to big drops, even with solid fundamentals. It fell 50% during the 2008 crisis and took a 45% hit in the 2020 pandemic selloff. The 2011 European debt crisis saw a 30% dip, while the 2015 Chinese market turmoil pushed it down 35%. Even quieter times brought 20% declines. Good business doesn’t mean steady stock, especially when markets turn sour. Volatility is part of the game.
But the risk is not limited to major market crashes. Stocks fall even when markets are in good shape – think events like earnings, business updates, outlook changes. Read GEHC Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
Still not sure about GEHC stock? Consider the portfolio approach.
A Multi Asset Portfolio Beats Picking Stocks Alone
Markets move differently but a mix of assets smooths volatility. A multi asset portfolio keeps you invested and reduces the impact of sharp drops in any single area.
The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices